Aegeline

OTHER NAME(S): N-[2-hydroxy-2 (4-methoxyphenyl) ethyl]-3-phenyl-2-propenamide, Aegeline, Aegelina, Aegéline

Overview

Aegeline is a chemical found in the bael plant. It is also made in a laboratory.

Despite safety concerns, aegeline has been used for weight loss, athletic performance, and increased energy, but there is no good scientific evidence to support these uses.

Aegeline has been included in dietary supplements marketed for weight loss and muscle building. In 2013, the U.S. Food and Drug Administration (FDA) issued warning letters to the manufacturer of these products stating that aegeline is not recognized as a lawful ingredient for supplements.

There is not enough information to know how aegeline might work.

There is not enough information to know how aegeline might work.

References
  1. Narender, T., Shweta, S., Tiwari, P., Papi, Reddy K., Khaliq, T., Prathipati, P., Puri, A., Srivastava, A. K., Chander, R., Agarwal, S. C., and Raj, K. Antihyperglycemic and antidyslipidemic agent from Aegle marmelos. Bioorg.Med Chem Lett. 2007;17(6):1808-11.
  2. Johnston DI, Chang A, Viray M, et al. Hepatotoxicity associated with the dietary supplement OxyELITE Pro - Hawaii, 2013. Drug Test Anal. 2016;8(3-4):319-27.
  3. Manda VK, Avula B, Chittiboyina AG, Khan IA, Walker LA, Khan SI. Inhibition of CYP3A4 and CYP1A2 by Aegle marmelos and its constituents. Xenobiotica. 2016;46(2):117-25.
  4. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-. OxyELITE Pro. [Updated 2016 May 20]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK548935/.
  5. Klontz KC, DeBeck HJ, LeBlanc P, et al. The Role of Adverse Event Reporting in the FDA Response to a Multistate Outbreak of Liver Disease Associated with a Dietary Supplement. Public Health Rep. 2015;130(5):526-532.
  6. Chatham-Stephens K, Taylor E, Chang A, et al. Hepatotoxicity associated with weight loss or sports dietary supplements, including OxyELITE Pro - United States, 2013. Drug Test Anal. 2017;9(1):68-74.
  7. Heidemann LA, Navarro VJ, Ahmad J, et al. Severe acute hepatocellular injury attributed to OxyELITE Pro: A case series. Dig Dis Sci. 2016;61(9):2741-8.
  8. Roytman MM, Pörzgen P, Lee CL, et al. Outbreak of severe hepatitis linked to weight-loss supplement OxyELITE Pro. Am J Gastroenterol. 2014;109(8):1296-8.
  9. Skinner CM, Miousse IR, Ewing LE, et al. Impact of obesity on the toxicity of a multi-ingredient dietary supplement, OxyELITE Pro (New Formula), using the novel NZO/HILtJ obese mouse model: Physiological and mechanistic assessments. Food Chem Toxicol. 2018;122:21-32.
  10. Manda VK, Haron MH, Mir TM, et al. Pharmacokinetics and tissue distribution of aegeline after oral administration in mice. Planta Med. 2019;85(6):491-495.
  11. Singh A, Srinivasan AK, Chakrapani LN, Kalaiselvi P. LOX-1, the common therapeutic target in hypercholesterolemia: A new perspective of antiatherosclerotic action of aegeline. Oxid Med Cell Longev. 2019;2019:8285730.
  12. Nugroho AE, Riyanto S, Sukari MA, Maeyama K. Effects of aegeline, a main alkaloid of Aegle Marmelos Correa leaves, on the histamine release from mast cells. Pak J Pharm Sci. 2011;24(3):359-67.